Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer

Annals of Surgical Oncology

Volumn 18, Issue 2, 2011, Pages 358-364

  Eom, Bang Wool ^a   Ryu, Keun Won ^a   Lee, Jun Ho ^a   Choi, Il Ju ^a   Kook, Myeong Cherl ^a   Cho, Soo Jeong ^a   Lee, Jong Yeul ^a   Kim, Chan Gyoo ^a   Park, Sook Ryun ^a   Lee, Jong Seok ^a   Kim, Young Woo ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUOROPYRIMIDINE; IRINOTECAN; PLATINUM; TAXANE DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; ASPIRATION BIOPSY; BLOOD CELL COUNT; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC BIOPSY; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; STOMACH CANCER; THORAX RADIOGRAPHY; TUMOR DIFFERENTIATION;

CONTINUITY OF PATIENT CARE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79951550129     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1395-3     Document Type: Article

References (28)

1. Department of Population Tendency of Korea National Statistical Office. Mortality and the cause of death in 2007. Seoul: Korea National Statistical Office; 2008.
2. Ministry for health, welfare, and family affairs. Cancer incidence in 2006-2007. Seoul: National Cancer Information Center; 2009.
3. Townsend CM, Beauchamp RD, Evers BM, Mattox KL. Sabiston textbook of surgery: the biological basis of modern surgical practice. 18th ed. Philadelphia: Saunders; 2008.
4. Y Kodera S Ito Y Yamamura, et al. 2003 Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit Ann Surg Oncol. 10 898 902 10.1245/ASO.2003.12.009 14527908 (Pubitemid 40486854)
5. H Böhner T Zimmer W Hopfenmüller G Berger HJ Buhr 2000 Detection and prognosis of recurrent gastric cancer-is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 47 1489 1494 11100384
6. JJ Bennett M Gonen M D'Angelica DP Jaques MF Brennan DG Coit 2005 Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 201 503 510 10.1016/j.jamcollsurg.2005.05.033 16183487 (Pubitemid 41393070)
7. H Hur KY Song CH Park HM Jeon 2010 Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea Ann Surg Oncol. 17 54 64 10.1245/s10434-009-0676-1 19777193
8. Japanease Gastric Cancer Association 1998 Japanese classification of gastric carcinoma, 2nd English edition Gastric cancer. 1 10 24 10.1007/PL00011681
9. Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58:215-21. Erratum: Clin Radiol. 2003;58:570. (Pubitemid 36335946)
10. Sobin LH, Wittekind C (editors). TNM classification of malignant tumours. 6th ed (UICC). New York: Wiley; 2002.
11. K Kafadar PC Prorok 2009 Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected Stat Med. 28 2116 2146 10.1002/sim.3601 19424959
12. JD Mahnken W Chan DH Freeman Jr JL Freeman 2008 Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach Stat Methods Med Res. 17 643 663 10.1177/0962280207087309 18445697 Review
13. WC Black 2006 Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests J Clin Oncol. 24 3252 3260 10.1200/JCO.2006.06.5573 16829649 Review (Pubitemid 46622066)
14. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg. 87 236 242 1:STN:280: DC%2BD3c7jslymsQ%3D%3D 10.1046/j.1365-2168.2000.01360.x 10671934 (Pubitemid 30088655)
15. J Whiting T Sano M Saka T Fukagawa H Katai M Sasako 2006 Follow-up of gastric cancer: a review Gastric Cancer. 9 74 81 10.1007/s10120-006-0360-0 16767361 Review (Pubitemid 43890702)
16. F Tas N Faruk Aykan A Aydiner V Yasasever E Topuz 2001 Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer Am J Clin Oncol. 24 148 149 1:STN:280: DC%2BD3M3jtVOrtQ%3D%3D 10.1097/00000421-200104000-00010 11319289 (Pubitemid 32323352)
17. IR Lai WJ Lee MT Huang HH Lin 2002 Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterology. 49 1157 1160 12143226
18. Y Takahashi T Takeuchi J Sakamoto, et al. 2003 The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study Gastric Cancer. 6 142 145 10.1007/s10120-003-0240-9 14520526 (Pubitemid 37221564)
19. IT Tan BY So 2007 Value of intensive follow-up of patients after curative surgery for gastric carcinoma J Surg Oncol. 96 503 506 10.1002/jso.20823 17680634 (Pubitemid 350044394)
20. K Kinkel Y Lu M Both RS Warren RF Thoeni 2002 Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis Radiology. 224 748 756 10.1148/radiol.2243011362 12202709 (Pubitemid 34919808)
21. EK Insko MS Levine BA Birnbaum JE Jacobs 2003 Benign and malignant lesions of the stomach: evaluation of CT criteria for differentiation Radiology. 228 166 171 10.1148/radiol.2281020623 12759472 (Pubitemid 36736085)
22. H Jadvar R Tatlidil AA Garcia PS Conti 2003 Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography (erratum appears in Clin Radiol 2003 Jul;58:570) Clin Radiol. 58 215 221 1:STN:280: DC%2BD3s7isFCntw%3D%3D 10.1016/S0009-9260(02)00477-4 12639527 (Pubitemid 36335946)
23. GIVIO investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA. 1994;271:1587-92.
24. T Küchler B Bestmann S Rappat D Henne-Bruns S Wood-Dauphinee 2007 Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial J Clin Oncol. 25 2702 2708 10.1200/JCO.2006.08.2883 17602075 (Pubitemid 47123177)
25. AG Renehan M Egger MP Saunders ST O'Dwyer 2002 Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials BMJ. 324 813 816 10.1136/bmj.324.7341.813 11934773 (Pubitemid 34280732)
26. M Jefferu BE Hickey PN Hider 2008 Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database Syst Rev. 16 CD003860
27. CE Desch AB Benson III TJ Smith, et al. 1999 Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology J Clin Oncol. 17 1312 1321 1:STN:280:DC%2BD3c%2FivF2hsQ%3D%3D 10561194 (Pubitemid 29162959)
28. NJ Petrelli EP Winer J Brahmer, et al. 2009 Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening-A Report From the American Society of Clinical Oncology J Clin Oncol. 27 6052 6069 10.1200/JCO.2009.26.6171 19901123